Back in 2003 MBO sued Becton, Dickinson for infringement of Reissue Patent No. 36,885 directed to a safety syringe design. Becton had won several District Court victories along the way, only to have them reversed (twice) by the Federal Circuit. Once again, Becton has prevailed at the District Court. Only time will tell if the decision holds up.
Here’s a quick recap of the case history:
In the ruling Judge Stearns noted several structural differences between the claims and the accused product including the accused product’s lack of a retractable needle, failure to “immediately” preclude needle-stick injury, and lack of a spring urged flange over the body front. The court also noted that MBO failed to prove direct infringement regarding activation of the needle protection device, a common problem with medical device claims that are dependent upon activity of a medical practitioner. The court also found that MBO failed to show infringement through doctrine of equivalents.
Now let’s see what the Federal Circuit does this time around.
MBO Labs., Inc. v. Becton, Dickinson & Co., 03-10038-RGS (D. Mass. May 6, 2011)
03-10038-RGS
Comments